Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Wegovy can cause excess gas. Clinical trial data consistently show that bloating, flatulence and burping are among the most commonly reported side effects of semaglutide, sitting alongside nausea and constipation as part of its well-documented gastrointestinal profile. Most people notice these symptoms most sharply in the first few weeks of treatment or after a dose increase, and they tend to settle as the body adjusts. These are prescription-only medicines, so a clinician will assess whether semaglutide is appropriate for you before any treatment begins — and that conversation is the right place to raise any concerns about how your gut might respond.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The science here starts with how Wegovy works. Semaglutide activates GLP-1 receptors in the gut and brain, which slows the rate at which food leaves your stomach. That delayed gastric emptying is precisely why appetite falls on the medicine, meals sit longer and fullness signals persist. The trade-off is that food fermenting for longer in the digestive tract produces more gas. Bacteria in the large intestine get more time to break down carbohydrates that weren't fully digested higher up, and the result is flatulence, bloating and, for some people, frequent burping.
This mechanism is described in the NHS semaglutide medicines page, which lists bloating and flatulence alongside the wider gastrointestinal side-effect profile. It is not a sign that something has gone wrong, it reflects the medicine doing exactly what it is designed to do. That said, how pronounced the effect is varies considerably from person to person, and for some it is barely noticeable at all.
If you want a fuller picture of what to expect across the range of semaglutide side effects, the semaglutide overview page on this site is a useful reference before you start.
The STEP 1 trial (a 68-week phase 3 study of semaglutide 2.4mg versus placebo in adults with obesity, published in the New England Journal of Medicine (2021)) is the most cited piece of evidence underpinning Wegovy's UK licence. Gastrointestinal events were the most commonly reported adverse effects in the active treatment group. Nausea, diarrhoea, vomiting and constipation led the list by frequency, but bloating and flatulence were recorded consistently throughout the trial, particularly in the dose-escalation phase when participants were stepping up from 0.25mg through to 2.4mg.
The pattern the STEP 1 data reveal is worth knowing. Most GI symptoms clustered around the weeks when the dose was being increased, then fell back once participants settled at a stable level. That gradient matters: the question of whether Wegovy makes you gassy does not have a single answer across all 68 weeks of treatment. It has a higher-risk period (early on) and a lower-risk steady state for most people.
A sister concern that comes up repeatedly is whether semaglutide more broadly causes this across different formulations; the short answer is yes, the mechanism is the same regardless of brand or format.
The evidence on dietary modification alongside GLP-1 treatment is not from dedicated RCTs, but the clinical logic is solid and the advice is consistent across NHS guidance and prescribers' experience. Smaller, more frequent meals put less fermentable load into your gut at once. Eating slowly gives your stomach more time to process food before it moves on. Reducing portions of known gas-producing foods (cruciferous vegetables like broccoli and cabbage, pulses, carbonated drinks) is a straightforward first step many people find genuinely helpful.
There is also a carbohydrate angle worth knowing about. Because semaglutide slows digestion, refined carbohydrates can sit around longer and feed gut bacteria more readily. The relationship between Wegovy and carbohydrates is worth reading if you find gassiness is worse after starchy or sugary meals. Staying well hydrated helps keep the bowel moving, which in turn reduces gas build-up.
One practical note: if you are starting Wegovy around a busy period (around a bank holiday, for example, or Christmas week) it can be worth timing your first pen so the most likely gassy days fall when you are at home and eating simply rather than in a restaurant. Small planning, real difference.
If symptoms are severe enough to disrupt daily life or are accompanied by persistent, intense abdominal pain that radiates to the back, that warrants medical attention promptly. The MHRA updated its guidance for GLP-1 medicines in January 2026 to highlight acute pancreatitis as an infrequent but serious risk, and severe stomach pain is the key warning sign to act on.
For most people, the worst of it is over within one to three weeks of starting a new dose. The gut adapts to reduced gastric motility gradually, and most trial participants who stuck with the medicine reported that GI side effects including bloating and flatulence diminished meaningfully once they reached a stable dose. That does not mean zero gas, it means the kind of manageable background effect that dietary habits can largely control.
Some people find gassiness returns briefly each time they step up to the next strength in the titration schedule. That is consistent with the mechanism: a higher dose slows gastric emptying a little more, the gut takes a week or two to recalibrate. It is worth mentioning to your prescriber if the pattern is disrupting sleep or meals, because there is clinical flexibility around the pace of titration.
If you are curious about the specifics of this side effect, our guide to being gassy on Wegovy goes into more detail on what patients typically experience and how to manage it, and if you want to understand why Wegovy makes you gassy and what you can do about it, that page covers the experience in detail. And for a broader look at the Wegovy treatment journey and what eligibility involves, the Wegovy treatment page covers the full picture. If you are still deciding whether this is the right route for you, the weight-loss treatment overview sets out the options side by side.
These are prescription-only medicines and every person's gut response is individual. If the symptoms are making you question whether to continue, the right conversation is with your prescriber, not a dosing pause made alone. You can start a free consultation with the nume clinical team to talk through semaglutide's side-effect profile and whether it fits your situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.